Crux gets FDA nod for inferior vena cava filter
Article Thumbnail ImageJuly 19, 2012 -- Crux Biomedical has received U.S. Food and Drug Administration (FDA) clearance for its inferior vena cava filter (VCF) with bidirectional retrieval.
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • The Crux VCF is designed to facilitate bidirectional retrieval through either the femoral or jugular veins, according to the company. In a recently completed trial presented at the 2012 Society for Interventional Radiology (SIR) meeting, researchers found a 98% success rate for both filter deployment and retrieval in 125 patients from 22 sites in the U.S., Australia, New Zealand, and Belgium.

    No embolizations, migrations, or fractures were observed at six-month follow-up, Crux said.


    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.